The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients

Annals of Surgical Oncology

Volumn 16, Issue 3, 2009, Pages 571-577

  Morton, Rachael L ^a,b   Craig, Jonathan C ^a   Thompson, John F ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; THORAX RADIOGRAPHY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RISK ASSESSMENT; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 60449094536     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0207-5     Document Type: Article

References (29)

1. JE Gershenwald W Thompson PF Mansfield 1999 Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 976 83
2. BM Clary MS Brady JJ Lewis 2001 Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg Oncol 233 250 8
3. C Chao SL Wong MI Ross 2002 Patterns of early recurrence after sentinel lymph node biopsy for melanoma Am J Surg 184 520 4
4. DL Morton JF Thompson AJ Cochran 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 28 1307 17
5. LA Gorenstein JB Putnam G Natarajan 1991 Improved survival after resection of pulmonary metastases from malignant melanoma Ann Thorac Surg 52 204 10
6. R Essner 2003 Surgical treatment of melanoma Surg Clin North Am 83 109 56
7. Mackie RM, Casinelli N, Ross MI, et al. Clinical management of melanoma. WHO melanoma programme. Milan: Melanoma publications; 1996.
8. DL Roberts AV Anstey RJ Barlow 2002 UK guidelines for the management of cutaneous melanoma Br J Dermatol 146 7 17
9. JJ van Everdingen HJ van der Rhee CC Koning 2005 Guidelines to melanoma, 3rd revision Ned Tijdschr Geneeskd 149 1839 43
10. Australian Cancer Network. Clinical Practice Guidelines: the management of cutaneous melanoma. NHMRC. Canberra: Commonwealth Department of Health; 1999.
11. DL Damian MJ Fulham E Thompson 1996 Positron emission tomography in the detection and management of metastatic melanoma Melanoma Res 6 325 9
12. Bland M. An Introduction to Medical Statistics. 3rd ed. Oxford: Oxford University Press; 2000.
13. U Hofmann M Szedlak W Rittgen 2002 Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival Br J Cancer 87 151 7
14. H Tsao M Feldman JE Fullerton 2004 Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival Arch Dermatol 140 67 70
15. M Weiss CL Loprinzi ET Creagan 1995 Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1703 5
16. DA Grimes KF Schultz 2002 Uses and abuses of screening tests Lancet 359 881 4
17. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical Epidemiology-A Basic Science for Clinical Medicine. 2nd ed. Boston: Little, Brown; 1991.
18. MJ Dalrymple-Hay PD Rome C Kennedy 2002 Pulmonary metastatic melanoma-the survival benefit associated with positron emission tomography scanning Eur J Cardiothorac Surg 21 611 4
19. L Tafra PS Dale LA Wanek 1995 Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax J Thorac Cardiovasc Surg 110 119 28
20. DG Coit 1993 Role of surgery for metastatic malignant melanoma: a review Semin Surg Oncol 9 239 45
21. IF Gareen 2007 Noncompliance in cancer screening trials Clin Trials 4 341 9
22. H Kittler R Weitzdorfer H Pehamberger 2001 Compliance with follow-up and prognosis among patients with thin melanomas Eur J Cancer 37 1504 9
23. OE Nieweg BR Kroon 2006 The conundrum of follow-up. Should it be abandoned? Surg Oncol Clin N Am 15 319 30
24. J Kelly M Henderson V Thursfield 2007 The management of primary cutaneous melanoma in Victoria Med J Aust 187 511 4
25. MM Fields E Chevlen 2006 Screening for disease: making evidence-based choices Clin J Oncol Nurs 10 73 6
26. PM McGovern CR Gross RA Krueger 2004 False-positive cancer screens and health-related quality of life Cancer Nurs 27 347 52
27. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult (review). Cochrane Database Syst Rev. 2007;(1):CD001216.
28. CA Baughan VL Hall BJ Leppard 1993 Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol 5 174 80
29. McCaffery K, Michie S. Monitoring as a learning and motivational tool. In: Glasziou PP, Irwig L, Aronson JK, editors. Evidence-based Medical Monitoring: From Principles to Practice. Oxford: Blackwell; 2008. p 123-39.